What We Do
Defective Medical Products
- Medicines
- Accutane Lawsuit
- Apothecure Colchicine Lawsuit
- Bismacine Chromacine
- Carbinoxamine
- Colistimethate Lawsuit Lawyer
- Complete Moistureplus Recall
- Fosamax Osteonecrosis Jaw
- Heparin Induced Thrombocytopenia Thrombosis
- Ketek Liver Failure
- Ortho Evra Birth Control Patch
- Promethazine
- Rocephin Death
- Topical Anesthetic
- Trasylol
- Zelnorm Heart Attack Stroke Lawsuit
- Medical Equipment
- FDA Recalls
- Guidant Recalls
- News & Topics
- Archives
Welcome to Pritzker | Ruohonen
Ortho Evra Patch and Stroke
Free Case Consultation
Unsafe Medical Featured Topics
Deaths Prompt Warnings for Haldol
The WARNINGS section of the prescribing information for Haldol (haloperidol, an antipsychotic medication), a Johnson & Johnson product, has been revised to include a new cardiovascular (heart-related) subsection regarding cases of sudden death, QT prolongation and torsades de pointes(TdP) in patients treated with haloperidol, especially when given intravenously, or at doses higher than recommended. Read more about haloperidol and a Haldol (haloperidol) lawsuit.
Deaths of Patients Treated with FENTORA
There have been serious, adverse events, including deaths in patients treated with FENTORA (fentanyl buccal tablet). According to the manufacturer of FENTORA, Cephalon, “These deaths occurred as a result of improper patient selection (e.g., use in opioid non-tolerant patients), improper dosing, and/or improper product substitution.” Read FENTORA lawsuit and lawyer information.
New Boxed Warning for Xolair
Anaphylaxis (severe allergic reaction) has occurred in some patients who were administered Xolair, an asthma medication manufactured by Genentech, Inc. 15% of the reported cases required hospitalization. Learn more about the Xolair boxed warning.
Ceftin, Fortaz, Rocephin, and Zinacef
Ceftin, Fortaz, Rocephin, and Zinacef (cephalosporin-based antibiotic medications) can cause pseudomembranous colitis, severe inflammation in areas of the colon (large intestine). Children are particularly susceptible to developing antibiotic-related colitis, which can cause serious illness and death. Read about the new label precautions and warnings for Ceftin, Fortaz, Rocephin, and Zinacef.
Continued Risks of Duragesic and Fentanyl
In July of 2005, the FDA issued an advisory regarding reports of death and other serious side effects from overdoses of fentanyl in patients using fentanyl transdermal (skin) patches for pain control. Deaths and overdoses had occurred in patients using both the brand name product Duragesic and the generic product (at the time there was only one generic product).
Complete Moisture Plus Recall
The FDA has announced that many consumers may not be aware of the May 2007 recall of Complete MoisturePlus Multipurpose Contact Lens Solution manufactured by Advanced Medical Optics (AMO). Learn more about the recall and a Complete Moisture Plus lawsuit.
Infant Deaths May Be Linked to Rocephin
Rocephin (ceftriaxone sodium) may be linked to the deaths of newborn infants. The babies most at risk are premature infants who are hyperbilirubinemic (a condition associated with jaundice). Learn more about Rocephin and the risk of death or injury.
Colistimethate May Have Caused Death
The FDA has received a report about the death of a patient with cystic fibrosis (CF) who used the antibiotic Colistimethate that had been premixed by a pharmacy into a liquid for inhalation with a nebulizer. Learn more about Colistimethate.
